Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BCHT Bio Pays $21 Million for 20% Stake in mRNA Vaccine Company; Will Acquire the Rest

publication date: Jun 29, 2023

Changchun BCHT Biotechnology, a vaccine company, announced a long-term plan to acquire Transcend Biomedical Suzhou, a mRNA vaccine developer. Initially, BCHT will pay $21 million for a 20% stake in Transcend. The two companies have signed a stepped agreement allowing BCHT to acquire additional Transcend share based on Transcend’s achieving specific development milestones. The companies expect BCHT will complete the takeover in the next three to four years. Transcend is a full-process mRNA startup developing a pipeline of vaccines with expertise in product design, synthesis, pilot production and quality control. More details....

Stock Symbol: (SHA: 688276)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here